Page last updated: 2024-08-18

pyrroles and Smoking Cessation

pyrroles has been researched along with Smoking Cessation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coates, LC; Deal, C; Deodhar, A; Dubreuil, M; Dunham, J; Gladman, DD; Gottlieb, A; Guyatt, G; Husni, ME; Jonsson, AH; Kenny, S; Kwan-Morley, J; Lin, J; Magrey, M; Marchetta, P; Mease, PJ; Merola, JF; Miner, J; Nowell, WB; Ogdie, A; Orbai, AM; Reddy, SM; Reston, J; Ritchlin, CT; Scher, JU; Shah, AA; Siaton, B; Siegel, E; Siegel, M; Singh, JA; Smith, BJ; Sullivan, N; Turgunbaev, M; Turner, AS; Van Voorhees, AS; Walsh, JA	1
Bonaca, MP; Creager, MA	1
Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M	1
Benz, R; Suter, PM	1

Reviews

2 review(s) available for pyrroles and Smoking Cessation

Article	Year
Pharmacological treatment and current management of peripheral artery disease. Circulation research, 2015, Apr-24, Volume: 116, Issue:9 Topics: Atorvastatin; Exercise; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Smoking Cessation; Treatment Outcome	2015
[Low HDL-cholesterol, high triglycerides--well known but often ignored]. Praxis, 2004, Nov-10, Volume: 93, Issue:46 Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric Acid; Combined Modality Therapy; Exercise; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Metabolic Syndrome; Niacin; Pyrroles; Risk Factors; Smoking Cessation; Triglycerides; Weight Loss; World Health Organization	2004

Article

Year

Pharmacological treatment and current management of peripheral artery disease.

Circulation research, 2015, Apr-24, Volume: 116, Issue:9

Topics: Atorvastatin; Exercise; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Smoking Cessation; Treatment Outcome

2015

[Low HDL-cholesterol, high triglycerides--well known but often ignored].

Praxis, 2004, Nov-10, Volume: 93, Issue:46

Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric Acid; Combined Modality Therapy; Exercise; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Metabolic Syndrome; Niacin; Pyrroles; Risk Factors; Smoking Cessation; Triglycerides; Weight Loss; World Health Organization

2004

Other Studies

2 other study(ies) available for pyrroles and Smoking Cessation

Article	Year
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:1 Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Comorbidity; Diabetes Mellitus; Enthesopathy; Etanercept; Evidence-Based Medicine; Exercise; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-12; Interleukin-17; Interleukin-23; Occupational Therapy; Physical Therapy Modalities; Piperidines; Pyrimidines; Pyrroles; Rheumatology; Smoking Cessation; Societies, Medical; Spondylitis; Tumor Necrosis Factor-alpha; Ustekinumab; Weight Loss	2019
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge. BMJ case reports, 2011, Sep-13, Volume: 2011 Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans	2011

Article

Year

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:1

Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Comorbidity; Diabetes Mellitus; Enthesopathy; Etanercept; Evidence-Based Medicine; Exercise; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-12; Interleukin-17; Interleukin-23; Occupational Therapy; Physical Therapy Modalities; Piperidines; Pyrimidines; Pyrroles; Rheumatology; Smoking Cessation; Societies, Medical; Spondylitis; Tumor Necrosis Factor-alpha; Ustekinumab; Weight Loss

2019

Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.

BMJ case reports, 2011, Sep-13, Volume: 2011

Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans

2011